Sanggua tablets
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Tongji Hospital
Overview
Sanggua tablets is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Sanggua tablets clinical trials
Explore related
Medical disclaimer. This page summarizes research about Sanggua tablets for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.